There is power in self-confidence
Using patients’ cells
TeVido BioDevices is developing cutting-edge manufacturing techniques and combining that with advances in cellular therapy to create custom grafts that restore lost pigment.
Hypopigmentation or absence of skin color can be caused by disease, burns, and trauma to the skin, including surgery.
A patient may feel stressed, self-conscious, sad, ashamed or even devastated by the change in their appearance caused by loss of pigmentation.
Using a patient's melanocytes (pigment producing cells) TeVido will recreate the color that has been lost, improving outcomes and enhancing quality of life.
Leading vitiligo researcher to join biotech innovators in improving treatment outcomes for condition characterized by the appearance of white patches on skin. TeVido BioDevices (TeVido), a pioneer in cellular therapy to treat loss of pigmentation, today announced the appointment to the advisory board of Dr. John Harris, Director of the Vitiligo Clinic and Research Center Read more about TeVido BioDevices Announces Appointment of Dr. John Harris to Advisory Board[…]
Signal Magazine The National Science Foundation shares their philosophy on funding early stage technologies. TeVido is highlighted as an example. Read more at: Pursuing Big Ideas No One Else Dares
Austin Woman Magazine Laura Bosworth, the entrepreneur and CEO behind TeVido BioDevices, is transforming breast reconstruction for cancer survivors, one nipple at a time. Read the magazine here: 3D printing the way to better breasts after cancer
Austin Community News Read more: Startup aims to help cancer survivors
First Aired May 2016 The Best Medicine with Dr. Ken Miller – Radio Interview with Dr. Scott Collins and a panel of experts on breast cancer has aired on over 40 NPR stations with more in the works.
“TeVido BioDevices, uses 3-D printing to make custom breast implants and grafts. And they’re made from a woman’s own cells. Laura Bosworth joined KVUE in the studio Sunday to discuss the company.” http://www.kvue.com/life/startup-3d-prints-breast-implants-grafts_20160425030446972/152160017
The Atlantic Read more: From stem cells to 3D-printed nipples, breast reconstruction is a highly technical and constantly evolving field. The Atlantic covers news and analysis on politics, business, culture, technology, national, international and life on the official site of The Atlantic Magazine
CNBC Business Beyond Tomorrow TeVido BioDevices was named as a Top 5 Challenger in the Health & Medicine Category of the XCS Challenge presented in NYC during during the Exponential Finance Conference. CEO, Laura Bosworth was interviewed for this feature at the conference sponsored by CNBC and Singularity University.
TeVido took 3rd place in The RESI Innovation Challenge, showcasing cutting-edge life science technologies in poster displays. The Redefining Early Stage Investments (RESI) Conference is for early stage life sciences companies to source investors, create relationships, and eventually, get funding. Read More… Photo: Alejandro Zamorano, Director of Business Development, LSN | Laura Bosworth, CEO & co-founder, Read more about Winners Announced From Latest RESI Innovation Challenge[…]
CNBC and Singularity University invited some of the most exciting early stage companies in the world and brought them to Exponential Finance 2015 XCS Challenge. TeVido was named as a top 5 contender in the Health and Medicine category and had the opportunity to pitch at the event. Watch CNBC Interview of CEO, Laura Bosworth